Many programs are available from federal and state governments, non-profits, manufacturers, and other organizations to help you get the drugs you need at a reduced cost. Eligibility is often based on income, insurance or Medicare status, and other factors. You’ll need to apply through each program, either online, over the phone, or with your doctor's help. The following program is offered by the manufacturer of this drug.
|Program Name:||Pfizer RxPathways|
|How do I apply?||Go to the program website and follow the instructions on the page based on your medication. Complete the appropriate application and submit it by mail or fax.|
|What are the benefits?||You can receive your medication at no cost.|
|What are the restrictions?||Most people without insurance and with limited incomes will qualify.|
|Keep in mind||Insured and Medicare Part D patients may still be eligible for the program under certain eligibility criteria. Contact the program to find out more.|
You may find that filling a 90-day supply will reduce your total cost for this prescription. As an added bonus, you'll make fewer trips to the pharmacy, saving you time and money.
A couple of things to keep in mind: first, you may need a new prescription from your doctor that allows you to fill a 90-day quantity. Your insurance plan may also require that you fill through a mail order pharmacy for fills of more than a 30-day supply.
There may be other prescriptions in the same class (that work in the same way) that could treat your condition just as well at a much lower cost.
If you're taking an expensive brand-name-only drug, it may be worth asking your doctor if there are any other less expensive, generic, or over-the-counter options that might work for you.
It is possible that Relpax may become available as generic eletriptan after June 2017. Generics are typically much cheaper than the branded version of a drug.
This is the earliest possible generic release date based on patent expiration at this time. It is possible that eletriptan could become available sooner or later, depending on FDA approval, other patents, and whether any manufacturers decide to make a generic version of Relpax.